These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 12858449

  • 1. Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus.
    Riskalla MM, Somers EC, Fatica RA, McCune WJ.
    J Rheumatol; 2003 Jul; 30(7):1508-12. PubMed ID: 12858449
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
    Lourdudoss C, Vollenhoven Rv.
    Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study.
    Nannini C, Crowson CS, Matteson EL, Moder KG.
    Lupus; 2009 Apr; 18(5):394-9. PubMed ID: 19318390
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature.
    Conti F, Ceccarelli F, Perricone C, Massaro L, Cipriano E, Pacucci VA, Truglia S, Miranda F, Morello F, Alessandri C, Spinelli FR, Valesini G.
    Immunol Res; 2014 Dec; 60(2-3):270-6. PubMed ID: 25468307
    [Abstract] [Full Text] [Related]

  • 5. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
    Dittrich K, Ross S, Benz K, Amann K, Dötsch J.
    Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients.
    Pisoni CN, Sanchez FJ, Karim Y, Cuadrado MJ, D'Cruz DP, Abbs IC, Khamasta MA, Hughes GR.
    J Rheumatol; 2005 Jun; 32(6):1047-52. PubMed ID: 15940766
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis.
    Kazderova M, Jancova E, Rysava R, Merta M, Tesar V.
    Arch Med Res; 2008 Jan; 39(1):115-9. PubMed ID: 18068004
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil.
    Zahr N, Arnaud L, Marquet P, Haroche J, Costedoat-Chalumeau N, Hulot JS, Funck-Brentano C, Piette JC, Amoura Z.
    Arthritis Rheum; 2010 Jul; 62(7):2047-54. PubMed ID: 20506558
    [Abstract] [Full Text] [Related]

  • 9. The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.
    Galarza-Maldonado C, Kourilovitch MR, Molineros JE, Cardiel MH, Zurita L, Soroka NF, Yagur VY, Doukh N, Cervera R.
    Autoimmun Rev; 2010 Dec; 10(2):108-11. PubMed ID: 20804861
    [Abstract] [Full Text] [Related]

  • 10. Does mycophenolate mofetil prevent extra-renal flares in systemic lupus erythematosus? Results from an observational study of patients in a single practice treated for up to 5 years.
    Posalski JD, Ishimori Ml, Wallace DJ, Weisman MH.
    Lupus; 2009 May; 18(6):516-21. PubMed ID: 19395453
    [Abstract] [Full Text] [Related]

  • 11. Hypersensitivity to mycophenolate mofetil in systemic lupus erythematosus: diagnostic measures and successful desensitization.
    Szyper-Kravitz M, Sheinberg P, Sidi Y, Schiffenbauer Y, Trubniykov E, Shoenfeld Y.
    Int Arch Allergy Immunol; 2005 Dec; 138(4):334-6. PubMed ID: 16224194
    [Abstract] [Full Text] [Related]

  • 12. Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study.
    Abe Y, Tada K, Yamaji K, Tamura N.
    Biomed Res Int; 2021 Dec; 2021():8630596. PubMed ID: 33564682
    [Abstract] [Full Text] [Related]

  • 13. Invasive fungal infections in Argentine patients with systemic lupus erythematosus.
    Vinicki JP, Catalan Pellet S, Pappalardo C, Cruzat VC, Spinetto MA, Dubinsky D, Tiraboschi IN, Laborde HA, Nasswetter G.
    Lupus; 2013 Aug; 22(9):892-8. PubMed ID: 23861029
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus.
    Fassbinder T, Saunders U, Mickholz E, Jung E, Becker H, Schlüter B, Jacobi AM.
    Arthritis Res Ther; 2015 Apr 03; 17(1):92. PubMed ID: 25890338
    [Abstract] [Full Text] [Related]

  • 15. [The efficacy of mycophenolate mofetil for systemic lupus erythematosus].
    Suzuki D, Ogawa N, Sawada J, Kimoto O, Shimoyama K, Hayashi H.
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Aug 03; 32(4):263-8. PubMed ID: 19721347
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil-induced erythroid hypoplasia in a patient with systemic lupus erythematosus.
    Doherty T, Austin SK, Newell B, Kiely PD.
    Lupus; 2013 Feb 03; 22(2):213-5. PubMed ID: 23257406
    [Abstract] [Full Text] [Related]

  • 17. A national survey on current use of mycophenolate mofetil for childhood-onset systemic lupus erythematosus in Japan.
    Hara R, Miyazawa H, Nishimura K, Momoi T, Nozawa T, Kikuchi M, Sakurai N, Kizawa T, Shimamura S, Yasuda S, Hiromura K, Sada KE, Kawaguchi Y, Tamura N, Takei S, Takasaki Y, Atsumi T, Mori M.
    Mod Rheumatol; 2015 Feb 03; 25(6):858-64. PubMed ID: 26215483
    [Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
    Buratti S, Szer IS, Spencer CH, Bartosh S, Reiff A.
    J Rheumatol; 2001 Sep 03; 28(9):2103-8. PubMed ID: 11550982
    [Abstract] [Full Text] [Related]

  • 19. Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement.
    Yahya F, Jasmin R, Ng CT, Cheah TE, Sockalingam S.
    Int J Rheum Dis; 2013 Dec 03; 16(6):724-30. PubMed ID: 24119227
    [Abstract] [Full Text] [Related]

  • 20. Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.
    Feldman CH, Marty FM, Winkelmayer WC, Guan H, Franklin JM, Solomon DH, Costenbader KH, Kim SC.
    Arthritis Rheumatol; 2017 Feb 03; 69(2):387-397. PubMed ID: 27589220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.